Homeostatic Influence of Fig4 Outside of the Fab1‐Vac14‐Fig4 Complex in Saccharomyces cerevisiae
Molecular Microbiology · 2025
DOI: 10.1111/mmi.70018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Microbiology, 2025. Verfasst von Hannah E Reeves und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Trinity University, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins, Phosphotransferases (Alcohol Group Acceptor), Phosphoric Monoester Hydrolases. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Max and Minnie Tomerlin Voelcker Fund, National Institute of General Medical Sciences.
Abstract (Originalsprache)
The lipid phosphatase Fig4 is conserved in all eukaryotes and is associated with human neurological diseases for which there are currently no specific therapies. Fig4 functions in both the production and turnover of its lipid substrate, PI3,5P2, through participation in the Fab1‐Vac14‐Fig4 complex with its opposing kinase Fab1. The molecular mechanisms through which Fig4 influences PI3,5P2 production are not fully understood but are believed to require Fig4 binding to the scaffold protein Vac14. We unexpectedly found that multiple Fig4 disease‐related mutants that are impaired in binding to the Fab1‐Vac14‐Fig4 complex dominantly confer tolerance to rapamycin, an inhibitor of the Target of Rapamycin Complex 1 (TORC1), when expressed in Saccharomyces cerevisiae . Fig4‐dependent rapamycin tolerance is conferred under moderate heat stress, independent of Vac14 and Fig4 catalytic activity. Conversely, expression of catalytically dead Fig4 that binds stably to the Fab1‐Vac14‐Fig4 complex enhances rapamycin sensitivity. We propose that Fig4 disease‐related mutants alter TORC1 signaling through gain of function under these conditions through an abnormal or sustained interaction with an unknown factor, perhaps by altering PI3,5P2 production. Investigation of the mechanisms whereby Fig4 mutants alter rapamycin tolerance may provide new insights into Fig4 molecular functions with potential relevance for Fig4‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Trinity University, San Antonio, Texas, USA.
- Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Bethany S Strunk
Förderung
- NIGMS NIH HHS
- Max and Minnie Tomerlin Voelcker Fund
- National Institute of General Medical Sciences
Zitieren
APA
Reeves, H. E., King, A., Khan, I., Thomas, A., Chung, C., Sivaprakash, A., Hall, H. A., McGuire, C., Cruz, V., Habib, A., Dotson, L., Lee, S. R., Darbro, C. L., & Strunk, B. S. (2025). Homeostatic Influence of Fig4 Outside of the Fab1‐Vac14‐Fig4 Complex in Saccharomyces cerevisiae. Molecular Microbiology. https://doi.org/10.1111/mmi.70018
Vancouver
Reeves HE, King A, Khan I, Thomas A, Chung C, Sivaprakash A, et al. Homeostatic Influence of Fig4 Outside of the Fab1‐Vac14‐Fig4 Complex in Saccharomyces cerevisiae. Molecular Microbiology. 2025. doi:10.1111/mmi.70018
BibTeX
@article{Reeves2025,
author = {Reeves, Hannah E and King, Anna and Khan, Imran and Thomas, Asha and Chung, Corey and Sivaprakash, Anirudan and Hall, Harrison A and McGuire, Cole and Cruz, Victoria and Habib, Alim and Dotson, Lauren and Lee, Sophia R and Darbro, Caroline L and Strunk, Bethany S},
title = {Homeostatic Influence of Fig4 Outside of the Fab1‐Vac14‐Fig4 Complex in Saccharomyces cerevisiae},
journal = {Molecular Microbiology},
year = {2025},
doi = {10.1111/mmi.70018}
}
EUVIMED